Phase II prospective randomized multicenter study of Folfiri versus Folfiri Cox-2 inhibitor versus Folfiri followed by Cox-2 inhibitor in the first-line treatment of colo-rectal cancer

• Conditions: First-line treatment of colo-rectal cancer; MedDRA version: 6.1Level: PTClassification code 10061045

• Registration Number: EUCTR2004-000591-13-IT
• Lead Sponsor: ISTITUTO ONCOLOGICO ROMAGNOLO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-03-14
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 159

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified